AbCellera Biologics Inc. Employee Count
The employee counts AbCellera Biologics Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 562; Filing 2026-02-24.
- 2024-12-31: Employees (as filed) 596; Filing 2025-02-27.
- 2023-12-31: Employees (as filed) 586; Filing 2024-02-20.
- 2022-12-31: Employees (as filed) 495; Filing 2023-02-21.
- Available history
- 2020-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 562 full-time | 2026-02-24 | |
| 2024-12-31 | 596 full-time | 2025-02-27 | |
| 2023-12-31 | 586 full-time | 2024-02-20 | |
| 2022-12-31 | 495 full-time | 2023-02-21 | |
| 2021-12-31 | 386 full-time | 2022-02-25 | |
| 2020-12-31 | 206 full-time | 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |